Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acutus Medical, Inc. (AFIB)

1.58   -0.06 (-3.66%) 01-27 16:00
Open: 1.62 Pre. Close: 1.64
High: 1.68 Low: 1.57
Volume: 87,128 Market Cap: 45(M)

Technical analysis

as of: 2023-01-27 4:42:20 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.06     One year: 2.41
Support: Support1: 1.19    Support2: 0.84
Resistance: Resistance1: 1.76    Resistance2: 2.06
Pivot: 1.38
Moving Average: MA(5): 1.64     MA(20): 1.37
MA(100): 0.96     MA(250): 1.13
MACD: MACD(12,26): 0.1     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 83.1     %D(3): 84
RSI: RSI(14): 60.6
52-week: High: 2.36  Low: 0.47
Average Vol(K): 3-Month: 612 (K)  10-Days: 204 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ AFIB ] has closed below upper band by 26.9%. Bollinger Bands are 97.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 17 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.68 - 1.69 1.69 - 1.7
Low: 1.55 - 1.56 1.56 - 1.57
Close: 1.56 - 1.58 1.58 - 1.59

Company Description

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Headline News

Fri, 27 Jan 2023
Severe gum infections linked to heightened AFib risk - Cardiovascular Business

Thu, 26 Jan 2023
Study compares surgery to medication in some patients with AFib - WPLG Local 10

Wed, 25 Jan 2023
Atrial Fibrillation (Afib): How We Manage in 2023 and Beyond - Discover Muscatine

Wed, 25 Jan 2023
Bananas and AFib: What to Eat with Atrial Fibrillation - Healthgrades

Tue, 24 Jan 2023
The Differences Between Atrial Flutter and Atrial Fibrillation (AFib) - Healthgrades

Tue, 24 Jan 2023
You can finally take ECGs and track AFib on a Garmin smartwatch - Digital Trends

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 28 (M)
Shares Float 21 (M)
% Held by Insiders 4.2 (%)
% Held by Institutions 42 (%)
Shares Short 1,060 (K)
Shares Short P.Month 1,130 (K)

Stock Financials

EPS -4.49
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.03
Profit Margin (%) 0
Operating Margin (%) -693.8
Return on Assets (ttm) -43.9
Return on Equity (ttm) -89.9
Qtrly Rev. Growth -20.8
Gross Profit (p.s.) -0.56
Sales Per Share 0.55
EBITDA (p.s.) -3.61
Qtrly Earnings Growth 0
Operating Cash Flow -95 (M)
Levered Free Cash Flow -60 (M)

Stock Valuations

PE Ratio -0.36
PEG Ratio 0
Price to Book value 0.77
Price to Sales 2.85
Price to Cash Flow -0.48

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.